KPTI
Karyopharm Therapeutics Inc
1.80$
+5.3%
vs. previous close
Closing price · As of: Sep 17, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Karyopharm Therapeutics Inc (KPTI) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 09/11/2026 | Current report (8-K) | Karyopharm Therapeutics Inc. (KPTI): Entry into a Material Definitive Agreement; Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement; Unregistered Sales of Equity Securities; Other Events; Financial Statements and Exhibits | View report ↗ |
| 09/04/2026 | Ownership disclosure | Form SC 13G filed with the SEC | View document ↗ |
| 08/31/2026 | Current report (8-K) | Karyopharm Therapeutics Inc. (KPTI): Other Events | View report ↗ |
| 08/13/2026 | Current report (8-K) | Karyopharm Therapeutics Inc. (KPTI): Results of Operations and Financial Condition; Financial Statements and Exhibits | View report ↗ |
| 07/31/2026 | Current report (8-K) | Karyopharm Therapeutics Inc. (KPTI): Other Events | View report ↗ |
| 07/28/2026 | Ownership disclosure | Form SC 13G filed with the SEC | View document ↗ |
| 07/17/2026 | Current report (8-K) | Karyopharm Therapeutics Inc. (KPTI): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.